This webinar will discuss strategies for avoiding or overcoming obviousness rejections when drafting and prosecuting patent applications relating to chemical and biological compounds, compositions, and methods of use. Presenters Anne M. Reynolds, Ph.D., and Melissa E. Kolom will review recent case law concerning obviousness and its impact on prosecution of claims in the life science space.